Delivery Order SPE2DB22D1017-SPE2DB24FG2UQ
Award Date
8/8/24
Potential Completion Date
8/9/24
Potential Value
$2.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of 4,566,196,313 units of VYVANSE CAPS 30MG, a prescription medication. The contract has a firm fixed price of $13,819.32 and a completion date of October 25, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,886,373 units of the drug VYVANSE 60 MG CAPSULE 100S, with a ceiling value of $1,337.70. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 14, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, with a ceiling value of $3,516.78, is for the delivery of 4,566,526,139 units of the pharmaceutical product VYVANSE 30 MG CAPSULE 100S. The contract is a Firm Fixed Price Delivery Order with a period of performance through November 25, 2024. This award is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award is to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,565,171,639 units of the medication VYVANSE 40 MG CAPSULE 100S to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a total ceiling value of $3,004.41 and is a firm-fixed price delivery order that will run through July 17, 2024. This award is not associated with any set-aside program. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,723.44, is a delivery order for 4,562,885,207 units of the prescription drug VYVANSE 30 MG CAPSULE 100S. The contract has an ultimate completion date of November 22, 2023 and is a firm fixed-price arrangement. Amerisourcebergen holds a larger Indefinite Delivery Contract...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,343.49 firm fixed-price delivery order is for the supply of 4,563,886,982 units of VYVANSE 10 MG CAPSULE 100S. The contract has an ultimate completion date of March 8, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,840.78 firm fixed-price delivery order is for the supply of 4562462576 VYVANSE 40 MG CAPSULE 100S, a medication likely used to treat various medical conditions. The contract has an ultimate completion date of October 11, 2023. This award is associated with Amerisourcebergen's broader...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,120.14 firm-fixed-price delivery order is for the supply of VYVANSE 40 MG CAPSULE 100S, a pharmaceutical product. The contract has an ultimate completion date of February 20, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $2,041.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of VYVANSE 40 MG CAPSULE 100S, a pharmaceutical product. The contract has an ultimate completion date of January 24, 2025 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,993.30, is for the delivery of VYVANSE 40 MG CAPSULE 100S, a prescription medication. The contract has an ultimate completion date of February 25, 2025, and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite...